PFG Investments LLC Sells 556 Shares of CVS Health Corporation $CVS

PFG Investments LLC lessened its stake in CVS Health Corporation (NYSE:CVS) by 2.9% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,777 shares of the pharmacy operator’s stock after selling 556 shares during the quarter. PFG Investments LLC’s holdings in CVS Health were worth $1,295,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of CVS. Bell Investment Advisors Inc boosted its position in shares of CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC lifted its stake in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the last quarter. ORG Partners LLC boosted its holdings in shares of CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares in the last quarter. Saudi Central Bank acquired a new position in shares of CVS Health during the 1st quarter worth $34,000. Finally, Livelsberger Financial Advisory bought a new stake in shares of CVS Health during the 2nd quarter worth $35,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Baird R W upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Morgan Stanley lifted their price target on shares of CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Wolfe Research upped their price objective on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research report on Monday, September 22nd. Cantor Fitzgerald restated an “overweight” rating and issued a $78.00 target price on shares of CVS Health in a research report on Tuesday, August 26th. Finally, Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $78.25.

CVS Health Trading Up 0.8%

Shares of NYSE CVS opened at $77.48 on Friday. The stock has a market cap of $98.27 billion, a P/E ratio of 21.64, a price-to-earnings-growth ratio of 0.85 and a beta of 0.60. The firm has a 50 day moving average price of $70.37 and a two-hundred day moving average price of $67.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $77.76.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion for the quarter, compared to analysts’ expectations of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. CVS Health’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s payout ratio is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.